Diabetes & Insulin Resistance Tests Part 2
The Diabetes & Insulin Resistance Tests Part 2 panel includes 9 tests and 44 biomarkers for advanced insight into insulin production, pancreatic function, autoimmune diabetes markers, short-term glucose control, cholesterol particles, fat metabolism, and urine health. It complements Part 1 by expanding foundational glucose, insulin, inflammation, lipid, and kidney testing into deeper diabetes and insulin resistance risk evaluation.
- $2,408.39
- $527.95
- Save: 78.08%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Adiponectin
Apolipoprotein A1
Apolipoprotein B
Apolipoprotein B/A1 Ratio
Also known as: C-Terminal Insulin, Connecting peptide insulin, CPeptide, Insulin C-peptide, Proinsulin C-peptide
C-Peptide
Fructosamine
Also known as: Glutamic Acid Decarboxylase65 Antibody
Glutamic Acid
Glutamic Acid Decarboxylase 65 Antibody
IA-2 Antibody
Also known as: Ion Mobility, Cardio IQ Lipoprotein Fractionation, Ion Mobility , HDL Subfractions, IDL Subfractions, LDL Subfractions, Lipoprotein Fraction, Lipoprotein Fractionation, Lipoprotein Fractionation Ion Mobility Cardio IQ, Quest Diagnostics has replaced the VAP® Cholesterol Test with Lipoprotein Fractionation, Ion Mobility, Cardio IQ™ test
HDL Large
LDL Medium
LDL Particle Number
LDL Pattern
LDL Peak Size
LDL Small
Proinsulin
Also known as: UA, Complete, Urinalysis UA Complete, Urine Analysis, Complete
Amorphous Sediment (Only Reported If Detected)
Appearance
Bacteria
Bilirubin
Calcium Oxalate Crystals (Only Reported If Detected)
Casts (Only Reported If Detected)
Color
Crystals (Only Reported If Detected)
Glucose
Granular Cast (Only Reported If Detected)
Hyaline Cast
Ketones
Leukocyte Esterase
Nitrite
Occult Blood
Ph
Protein
Rbc
Reducing Substances (Only Reported If Detected)
Renal Epithelial Cells (Only Reported If Detected)
Specific Gravity
Squamous Epithelial Cells
Transitional Epithelial (Only Reported If Detected)
Triple Phosphate Crystals (Only Reported If Detected)
Uric Acid Crystals (Only Reported If Detected)
WBC
YEAST (Only Reported If Detected)
The Diabetes & Insulin Resistance Tests Part 2 panel contains 9 tests with 43 biomarkers .
Advanced Insight Into Insulin Production, Autoimmune Diabetes Risk, Cholesterol Particles, Urine Health, and Glucose Patterns
The Diabetes & Insulin Resistance Tests Part 2 panel includes 9 tests and 44 biomarkers designed to provide deeper insight into advanced diabetes risk, insulin production, pancreatic function, autoimmune diabetes markers, cholesterol particle patterns, short-term glucose control, fat metabolism, and urine health.
This panel goes beyond standard blood sugar screening by evaluating markers that may help clarify why glucose or insulin patterns are abnormal. It can be especially useful for people who want a more advanced look at insulin resistance, diabetes risk, metabolic syndrome, cardiovascular risk, and possible autoimmune contributors to blood sugar imbalance.
When used alongside Diabetes & Insulin Resistance Tests Part 1, this panel provides a more complete picture of metabolic health by expanding from foundational diabetes and insulin resistance testing into advanced insulin, antibody, lipid particle, and urine analysis.
How Part 2 Complements Diabetes & Insulin Resistance Tests Part 1
Diabetes & Insulin Resistance Tests Part 1 focuses on foundational metabolic markers such as glucose, Hemoglobin A1c, insulin, glucose tolerance, insulin response to glucose, inflammation, cholesterol, kidney risk, blood counts, and overall metabolic function.
Diabetes & Insulin Resistance Tests Part 2 expands that evaluation by adding advanced markers that help assess:
- Insulin production and pancreatic beta-cell function
- Autoimmune diabetes-related antibodies
- Shorter-term blood sugar trends
- Fat metabolism and insulin sensitivity
- Advanced cholesterol and lipoprotein particle patterns
- Urine health and possible kidney or metabolic clues
Together, Part 1 and Part 2 can help create a more comprehensive diabetes and insulin resistance profile. Part 1 helps identify broad blood sugar, insulin, inflammation, cholesterol, and kidney patterns, while Part 2 helps provide deeper insight into the mechanisms behind those patterns.
Why This Panel Matters
Diabetes and insulin resistance are not always caused by the same underlying issues. Some people may have elevated insulin levels from insulin resistance, while others may have reduced insulin production, pancreatic stress, autoimmune markers, or cholesterol particle patterns that increase cardiometabolic risk.
The Diabetes & Insulin Resistance Tests Part 2 panel helps evaluate important questions such as:
- Is the pancreas producing enough insulin?
- Are glucose patterns changing over the shorter term?
- Are autoimmune markers present that may affect insulin production?
- Are cholesterol particles showing increased cardiovascular risk?
- Are fat-cell hormones suggesting insulin resistance or metabolic dysfunction?
- Are there urine findings that may need follow-up?
This added layer of testing may help individuals and healthcare providers make more informed decisions about prevention, monitoring, lifestyle changes, and provider-guided care.
Who May Benefit From This Panel?
The Diabetes & Insulin Resistance Tests Part 2 panel may be helpful for people who want deeper insight into:
- Insulin resistance
- Prediabetes risk
- Type 2 diabetes risk
- Metabolic syndrome
- Unexplained blood sugar changes
- Abnormal A1c or glucose results
- Concerns about insulin production
- Family history of diabetes
- Possible autoimmune diabetes patterns
- Elevated cholesterol or cardiovascular risk
- Weight gain, belly fat, or metabolic slowdown
- Need for advanced follow-up after basic diabetes screening
This panel may also be useful for people who have already completed foundational testing and want a more detailed view of diabetes-related risk factors.
What Is Included in This Panel?
The Diabetes & Insulin Resistance Tests Part 2 panel includes the following tests:
- Adiponectin
- Apolipoprotein A1 + B
- C-Peptide
- Fructosamine
- Glutamic Acid Decarboxylase-65 Antibody
- IA-2 Antibody
- Lipoprotein Fractionation, Ion Mobility, Cardio IQ™
- Proinsulin
- Urinalysis, Complete
Test Details
Adiponectin
Adiponectin is a hormone produced by fat cells that helps regulate glucose metabolism and fatty acid breakdown. It plays an important role in insulin sensitivity and metabolic health.
Low adiponectin levels may be associated with insulin resistance, visceral fat, metabolic syndrome, and increased risk for type 2 diabetes. Measuring adiponectin can provide insight into how effectively the body supports fat metabolism and glucose regulation.
Apolipoprotein A1 + B
Apolipoprotein A1 and Apolipoprotein B provide information about cholesterol transport and cardiovascular risk.
Apolipoprotein A1 is associated with HDL cholesterol activity, which helps transport cholesterol away from arteries. Apolipoprotein B is found on atherogenic particles such as LDL and VLDL, which can contribute to plaque buildup. The balance between these markers can help evaluate cardiometabolic risk, especially in people with insulin resistance or diabetes risk.
C-Peptide
C-Peptide is released when the body produces insulin. Because it is created in equal amounts with insulin, it can help show how much insulin the pancreas is producing.
C-Peptide testing may help distinguish between low insulin production and insulin resistance. It can also provide insight into pancreatic beta-cell function, which is important when evaluating diabetes risk and blood sugar regulation.
Fructosamine
Fructosamine reflects average blood sugar levels over a shorter period than Hemoglobin A1c, typically about two to three weeks.
This test can be useful when recent changes in blood sugar control need to be evaluated or when A1c may not fully reflect short-term glucose patterns. It provides another way to assess how well blood sugar is being managed.
Glutamic Acid Decarboxylase-65 Antibody
Glutamic Acid Decarboxylase-65 Antibody, often called GAD-65 antibody, is an autoimmune marker that may be associated with autoimmune diabetes.
The presence of this antibody may suggest immune activity directed toward insulin-producing pancreatic cells. This can be helpful when evaluating possible type 1 diabetes, latent autoimmune diabetes in adults, or unexplained changes in insulin production.
IA-2 Antibody
IA-2 Antibody is another autoimmune diabetes-related marker. It may be present when the immune system is affecting pancreatic beta cells.
Testing IA-2 antibodies can help provide additional information when autoimmune diabetes is a concern, especially when blood sugar patterns do not fit typical insulin resistance or type 2 diabetes patterns.
Lipoprotein Fractionation, Ion Mobility, Cardio IQ™
Lipoprotein Fractionation by Ion Mobility provides an advanced look at cholesterol particle size and number. This can offer more detailed cardiometabolic risk information than a standard lipid panel alone.
People with insulin resistance or diabetes risk may have a higher number of small, dense LDL particles or other lipoprotein changes that can increase cardiovascular risk. This test helps evaluate cholesterol particle patterns that may not be obvious from basic cholesterol values.
Proinsulin
Proinsulin is the precursor molecule that is converted into insulin. Measuring proinsulin can help assess pancreatic beta-cell function and insulin processing.
Elevated proinsulin may suggest that the pancreas is under stress or working harder to produce insulin. This can be relevant in insulin resistance, early diabetes risk, and metabolic dysfunction.
Urinalysis, Complete
A complete urinalysis evaluates urine appearance, concentration, chemical markers, and microscopic findings. It may provide information about hydration, kidney function, urinary tract health, glucose in urine, protein in urine, and other metabolic or urinary concerns.
For diabetes and insulin resistance evaluation, urinalysis can help identify findings that may suggest glucose spillover, kidney stress, infection, or other issues that warrant follow-up.
How This Panel Can Help
The Diabetes & Insulin Resistance Tests Part 2 panel can help provide advanced insight into metabolic health by evaluating:
- Pancreatic insulin production
- Beta-cell stress and insulin processing
- Autoimmune diabetes-related markers
- Short-term blood sugar patterns
- Insulin sensitivity and fat metabolism
- Advanced cardiovascular risk through lipoprotein particle testing
- Urine findings related to kidney, glucose, and urinary health
This information can support more personalized conversations with a healthcare provider and may help guide next steps for prevention, monitoring, lifestyle changes, or additional testing.
Benefits of Ordering This Panel
Expands Beyond Standard Diabetes Screening
This panel includes advanced markers that go beyond glucose and A1c to evaluate insulin production, autoimmune antibodies, proinsulin, fructosamine, and lipid particle patterns.
Helps Clarify Insulin Production
C-Peptide and proinsulin can help provide insight into how the pancreas is producing and processing insulin.
Evaluates Autoimmune Diabetes Markers
GAD-65 antibody and IA-2 antibody may help identify autoimmune patterns that can affect insulin-producing cells.
Provides Advanced Cardiometabolic Risk Insight
Apolipoproteins and lipoprotein fractionation help evaluate cholesterol particle patterns that may be important in insulin resistance and diabetes-related cardiovascular risk.
Complements Foundational Diabetes Testing
When paired with Diabetes & Insulin Resistance Tests Part 1, this panel provides a more complete view of blood sugar control, insulin response, inflammation, cardiovascular risk, kidney risk, autoimmune markers, and pancreatic function.
Frequently Asked Questions
What is the Diabetes & Insulin Resistance Tests Part 2 panel?
The Diabetes & Insulin Resistance Tests Part 2 panel is an advanced blood and urine testing panel that evaluates insulin production, pancreatic function, autoimmune diabetes markers, short-term glucose patterns, advanced cholesterol particle risk, adiponectin, and urine health.
How many tests and biomarkers are included?
This panel includes 9 tests and 44 biomarkers.
How is Part 2 different from Diabetes & Insulin Resistance Tests Part 1?
Part 1 focuses on foundational diabetes and insulin resistance markers such as glucose, A1c, insulin, glucose tolerance, insulin response, CRP, CBC, CMP, lipids, and urine microalbumin. Part 2 adds advanced testing for insulin production, proinsulin, C-peptide, autoimmune antibodies, fructosamine, adiponectin, apolipoproteins, lipoprotein fractionation, and urinalysis.
Should Part 1 and Part 2 be ordered together?
Part 1 and Part 2 can complement each other. Part 1 provides a broad foundation for blood sugar, insulin response, inflammation, cholesterol, and kidney risk, while Part 2 provides deeper insight into pancreatic function, autoimmune diabetes markers, advanced lipid particles, and short-term glucose patterns.
Why is C-Peptide included?
C-Peptide helps show how much insulin the pancreas is producing. It can provide insight into whether abnormal glucose patterns may be related to low insulin production, insulin resistance, or pancreatic beta-cell function.
Why is proinsulin included?
Proinsulin helps evaluate how the pancreas is processing insulin. Elevated proinsulin may suggest beta-cell stress or increased demand for insulin production.
Why are GAD-65 and IA-2 antibodies included?
GAD-65 and IA-2 antibodies are autoimmune markers that may be associated with immune activity affecting insulin-producing pancreatic cells. They can be useful when autoimmune diabetes patterns are a concern.
Why is fructosamine included?
Fructosamine reflects average blood sugar over a shorter time period than A1c, usually about two to three weeks. It can help evaluate recent changes in glucose control.
Why is advanced lipoprotein testing included?
Insulin resistance and diabetes risk are often associated with cholesterol particle changes. Lipoprotein fractionation by ion mobility provides more detailed information about particle size and number, which may help evaluate cardiometabolic risk.
Does this panel diagnose diabetes?
This panel provides lab information that may help evaluate diabetes risk, insulin resistance, autoimmune markers, and related metabolic patterns. Diagnosis should be made by a qualified healthcare provider using lab results, symptoms, medical history, and clinical guidelines.
Take a Deeper Look at Diabetes and Insulin Resistance Risk
The Diabetes & Insulin Resistance Tests Part 2 panel provides advanced insight into the biological factors that may influence blood sugar control, insulin production, pancreatic function, autoimmune diabetes risk, cholesterol particle patterns, and urine health.
For the most complete view, consider how this panel works alongside Diabetes & Insulin Resistance Tests Part 1. Together, they can help build a more detailed picture of metabolic health, insulin resistance, diabetes risk, cardiovascular risk, and kidney-related concerns.
Order the Diabetes & Insulin Resistance Tests Part 2 panel today to gain deeper insight into your metabolic health.